GlassScriptPhysician profile
Michael D Daras
NPI 1972604700
$2,894.41
in general payments reported to CMS, 2019-2025
17 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,372 · 2020: $110 · 2021: $462 · 2022: $336 · 2023: $153 · 2024: $132 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edw Pharma, INC. | $660.97 | 2019 | |
| Abbvie INC. | $501.71 | 2022-2025 | Botox, Ubrelvy |
| Supernus Pharmaceuticals, INC. | $393.42 | 2019-2020 | |
| Allergan, INC. | $331.51 | 2019-2022 | |
| Celgene Corporation | $246.04 | 2021-2022 | |
| Eisai INC. | $178.30 | 2021-2025 | |
| Pfizer INC. | $138.28 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $124.69 | 2019-2022 | |
| Emd Serono, INC. | $95.74 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $68.50 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $36.33 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $24.96 | 2021 | |
| Janssen Pharmaceuticals, INC | $23.19 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.43 | 2022 | |
| Lundbeck LLC | $18.64 | 2025 | Vyepti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Strongbridge US INC. | $16.62 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Daras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.